Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19

Related articles

1. Structure-based computational screening and molecular dynamics reveal potential inhibitors of Norovirus VP1 and RdRp Proteins: an in-silico study

   This article has 9 authors:

   1. Hasan Huzayfa Rahaman
   2. Nadim Sharif
   3. Al Imran Kafi
   4. Wasifuddin Ahmed
   5. Nazmul Sharif
   6. Fuad M. Alzahrani
   7. Khalaf F. Alsharif
   8. Khalid J. Alzahrani
   9. Shuvra Kanti Dey

2. Structural Insights into DENV-2 NS2B-NS3 Protease and Inhibition by Glutathione-Coated Gold Nanocluster

   This article has 14 authors:

   1. Haojia Zhu
   2. Wenchao Niu
   3. Yuancong Xu
   4. Zhaoyang Li
   5. Dongfang Xia
   6. Sixu Chen
   7. Botao Zhang
   8. Junshuai Wang
   9. Huai Yang
   10. Xueyun Gao
   11. Yuanyuan Chen
   12. Yong Gong
   13. Peng Cao
   14. Yubai zhou

3. An Update on the Role of Penicillin Binding Protein-4 (PBP4) in β-Lactam Resistance of <em>Staphylococcus aureus</em>

   This article has 2 authors:

   1. Nidhi Satishkumar
   2. Som S. Chatterjee